| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
251,510,000 |
| Market
Cap: |
137.75(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$414.13 - $543.89 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 17 |
| Guru Rank Value : 22.1 |
| Guru Occurances : 4 |
|
|
|
|
|
| |
|
Company Profile Elevance Health is an insurance holding company. Co. is a health benefits company, serving medical members through its affiliated health plans. Co. has four segments: Commercial and Specialty Business, which provides fully-insured health products, managed care services; Government Business, which includes Medicare and Medicaid businesses, its subsidiary, National Government Services, and services provided to the federal government in connection with its Federal Health Products and Services business; IngenioRx, which includes its pharmacy benefit management business; and Other, which includes Diversified Business Group, which is its integrated health services business.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
44,753 |
52,053 |
52,427 |
77,577 |
| Total Sell Value |
$23,062,766 |
$26,598,808 |
$26,775,666 |
$38,325,083 |
| Total People Sold |
4 |
6 |
7 |
8 |
| Total Sell Transactions |
5 |
8 |
10 |
15 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Haytaian Peter D |
EVP & President, Commercial |
• • – |
2018-09-06 |
4 |
OE |
$60.15 |
$116,450 |
D/D |
1,936 |
58,642 |
|
- |
|
| Patel Prakash R |
EVP & President, DBG |
• • – |
2018-09-04 |
4 |
A |
$0.00 |
$0 |
D/D |
1,186 |
1,186 |
|
- |
|
| Penczek Ronald W |
SVP, Chief Accounting Officer |
• • – |
2018-09-04 |
4 |
S |
$265.56 |
$202,622 |
D/D |
(763) |
928 |
|
- |
|
| Penczek Ronald W |
SVP, Chief Accounting Officer |
• • – |
2018-09-04 |
4 |
OE |
$131.80 |
$113,119 |
D/D |
763 |
1,691 |
|
- |
|
| Haytaian Peter D |
EVP & President, Commercial |
• • – |
2018-08-27 |
4 |
AS |
$265.70 |
$930,724 |
D/D |
(3,500) |
56,706 |
|
- |
|
| Hill Julie A |
Director |
• • – |
2018-08-16 |
4 |
S |
$267.01 |
$66,218 |
D/D |
(248) |
34,827 |
|
- |
|
| Samitt Craig E |
EVP & President, DBG |
• • – |
2018-07-26 |
4 |
S |
$246.68 |
$4,820,374 |
D/D |
(19,541) |
17,274 |
|
- |
|
| Samitt Craig E |
EVP & President, DBG |
• • – |
2018-07-26 |
4 |
OE |
$131.80 |
$3,632,839 |
D/D |
25,804 |
36,815 |
|
- |
|
| Norwood Felicia F |
Exec VP & President, GBD |
• • – |
2018-07-02 |
4 |
A |
$0.00 |
$0 |
D/D |
1,784 |
1,784 |
|
- |
|
| Gallina John E |
EVP & Chief Financial Officer |
• • – |
2018-06-01 |
4 |
D |
$221.50 |
$60,913 |
D/D |
(275) |
15,659 |
|
- |
|
| Hill Julie A |
Director |
• • – |
2018-05-25 |
4 |
S |
$233.00 |
$233,000 |
D/D |
(1,000) |
35,075 |
|
- |
|
| Peru Ramiro G |
Director |
• • – |
2018-05-18 |
4 |
AS |
$231.57 |
$520,569 |
D/D |
(2,248) |
12,076 |
|
- |
|
| Dixon Robert L Jr |
Director |
• • – |
2018-05-18 |
4 |
S |
$231.10 |
$231,100 |
D/D |
(1,000) |
9,738 |
|
- |
|
| Jallal Bahija |
Director |
• • – |
2018-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
753 |
957 |
|
- |
|
| Dixon Robert L Jr |
Director |
• • – |
2018-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
753 |
10,738 |
|
- |
|
| Tallett Elizebeth E |
Director |
• • – |
2018-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
753 |
7,061 |
|
- |
|
| Peru Ramiro G |
Director |
• • – |
2018-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
753 |
14,324 |
|
- |
|
| Hay Lewis III |
Director |
• • – |
2018-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
753 |
7,676 |
|
- |
|
| Schaefer George A Jr |
Director |
• • – |
2018-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
753 |
38,864 |
|
- |
|
| Hill Julie A |
Director |
• • – |
2018-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
753 |
36,075 |
|
- |
|
| Neri Antonio F |
Director |
• • – |
2018-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
753 |
1,094 |
|
- |
|
| Clark R Kerry |
Director |
• • – |
2018-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
753 |
5,809 |
|
- |
|
| Griffin Brian T |
EVP & CEO, IngenioRx |
• • – |
2018-05-03 |
4 |
S |
$224.32 |
$13,334,390 |
D/D |
(59,421) |
15,863 |
|
- |
|
| Griffin Brian T |
EVP & CEO, IngenioRx |
• • – |
2018-05-03 |
4 |
OE |
$61.88 |
$6,961,995 |
D/D |
59,421 |
75,284 |
|
- |
|
| Mccarthy Gloria M |
EVP & Chief Administrative Off |
• • – |
2018-04-03 |
4 |
D |
$227.51 |
$41,862 |
D/D |
(184) |
38,840 |
|
- |
|
634 Records found
|
|
Page 13 of 26 |
|
|
3.82 (0.7%) 
